Journals / Karya Journal of Health Science / 2022 / Cilt: 3 - Sayı: 2

THE RELATIONSHIP BETWEEN HYPOGLYCEMIC CONFIDENCE AND HYPOGLYCEMIA FEAR IN TYPE 2 DIABETES MELLITUS PATIENTS

TİP 2 DİYABETES MELLİTUSLU HASTALARIN HİPOGLİSEMİK GÜVENLERİ VE HİPOGLİSEMİ KORKULARI ARASINDAKİ İLİŞKİ

Pages
85–92
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Type 2 diabetes patients’ HCS scores had moderately negative relationships with scores obtained by them from the HFS and its Behavior Sub-scale and Worry Sub-scale (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aims to identify the relationship between hypoglycemic confidence and hypoglycemia fear in type 2 diabetes mellitus patients.
📊
Key Findings & Data:Method: Designed as a descriptive and cross-sectional study, this research was conducted with 306 type 2 diabetes patients who visited the diabetes polyclinic to have an examination in period December 2021 and February 2022.
💡
Conclusion & Impact:Type 2 diabetes patients’ HCS scores had moderately negative relationships with scores obtained by them from the HFS and its Behavior Sub-scale and Worry Sub-scale (p
🔬Design:Survey & Empirical Study
📍Scope:2021 Verileri
⚙️Variables:Tip 2 Diyabetes Mellitus · Hipoglisemi · Korku

Abstract

Objective: This study aims to identify the relationship between hypoglycemic confidence and hypoglycemia fear in type 2 diabetes mellitus patients. Method: Designed as a descriptive and cross-sectional study, this research was conducted with 306 type 2 diabetes patients who visited the diabetes polyclinic to have an examination in period December 2021 and February 2022. The research data were collected by using the “Patient Identification Form”, the “Hypoglycemic Confidence Scale”, and the “Hypoglycemia Fear Survey”. Descriptive statistics, the Independent Samples t-test, the One-Way ANOWA test, the Pearson’s correlation test, and the linear regression analysis were used in the evaluation of research data. Results: In the research, 60.8% of the participant type 2 diabetes patients were female, their mean age was 55.14±8.10 years, and their mean duration of having the disease was 10.35±4.77 years. Means of type 2 diabetes patients’ Hypoglycemic Confidence Scale (HCS)’ score 1.65±0.47 and ‘Hypoglycemia Fear Survey (HFS)’ scores were 3.02±0.56 points. Type 2 diabetes patients’ HCS scores had moderately negative relationships with scores obtained by them from the HFS and its Behavior Sub-scale and Worry Sub-scale (p

Özet

Amaç: Bu çalışmanın amacı, tip 2 diyabetes mellituslu hastaların hipoglisemik güvenleri ve hipoglisemi korkuları arasındaki ilişkiyi belirlemektir. Yöntem: Tanımlayıcı ve kesitsel olarak tasarlanan bu araştırma, Aralık 2021 ve Şubat 2022 tarihleri arasında diyabet polikliniğine muayene olmak için gelen 306 tip 2 diyabetli hasta ile tamamlandı. Veriler, “Hasta Tanıtım Formu”, “Hipoglisemik Güven Ölçeği (HGÖ)” ve “Hipoglisemi Korku Ölçeği (HKÖ)” kullanılarak elde edildi. Verilerin değerlendirilmesinde, tanımlayıcı istatistikler, Independent-Samples t testi, One-Way ANOVA testi, Pearson Korelasyon ve Linear Regresyon analizi kullanıldı. Bulgular: Araştırmaya katılan Tip 2 diyabetli hastaların %60.8’i kadın olup yaş ortalaması 55.14±8.10 ve hastalık yılı ortalaması 10.35±4.77 idi. Tip 2 diyabetli hastaların HGÖ puan ortalamasının 1.65±0.47 ve HKÖ puan ortalamasının 3.02±0.56 olduğu belirlendi. HGÖ toplam puanı ile HKÖ toplam, HKÖ Davranış ve Kaygı alt boyutu arasında orta derecede negatif yönlü bir ilişki olduğu saptandı (p

🔖

Cite This Article

MENEKLİ, T., ŞENTÜRK, S. (2022). THE RELATIONSHIP BETWEEN HYPOGLYCEMIC CONFIDENCE AND HYPOGLYCEMIA FEAR IN TYPE 2 DIABETES MELLITUS PATIENTS. Karya Journal of Health Science, Cilt: 3 - Sayı: 2, 85–92. https://ajindex.com/articles/571467

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Rossi MC, Nicolucci A, Ozzello A, et al. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. Nutr Metab Cardiovasc Dis. 2019;29(7):736-743.
  2. Khunti K, Alsifri S, Aronson R, Berković MC, Enters-Weijnen C, Forsén T. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2017;130:121-129. Freeman J. Management of hypoglycemia in older adults with type 2 diabetes. Postgrad Med. 2019;131(4):241-250.
  3. Johnson-Rabbett B, Seaquist ER. Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review. J Diabetes. 2019;11(9):711-718.
  4. Ratzki-Leewing A, Harris SB, Mequanint S, et al. Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada. BMJ Open Diabetes Res Care. 2018;6(1):1-9.
  5. Emral R, Tetiker T, Sahin I, et al. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study. BMC Endocr Disord. 2018;18(1):1-11.
  6. Gonder-Frederick LA, Vajda KA, Schmidt KM, et al. Examining the behaviour subscale of the Hypoglycaemia Fear Survey: an international study. Diabet Med. 2013;30(5):603-609.
  7. Polonsky WH, Fisher L, Hessler D, Edelman SV. Investigating hypoglycemic confidence in Type 1 and Type 2 diabetes. Diabetes Technol Ther. 2017;19(2):131-136.
  8. Büyükkaya BD, Dervişoğlu M. Hipoglisemik güven ölçeği'nin geçerlik ve güvenirliği. Turkiye Klinikleri Hemşirelik Bilimleri. 2021;13(1):120-129.
  9. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10(5):617-621.
  10. Erol Ö, Enç N. Hypoglycemia fear and self-efficacy of Turkish patients receiving insulin therapy. Asian Nurs Res. 2011;5(4):222-228.
  11. Ahmad I, Zelnick LR, Batacchi Z, et al. Hypoglycemia in people with type 2 diabetes and CKD. Clin J Am Soc Nephrol. 2019;14(6):844-853.
  12. Wang JS, Chen H, Tang F, Sheu WHH. Associations of fear of hypoglycemia with second-line use of insulin secretagogues or insulin and subsequent glycemic control in patients with type 2 diabetes: An analysis using data from the DISCOVER study. Int J Clin Pract. 2020;74(6):e13485. Huang J, Ding S, Xiong S, Liu Z. The mediating effects of diabetes distress, anxiety, and cognitive